1. Home
  2. UNM vs NBIX Comparison

UNM vs NBIX Comparison

Compare UNM & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unum Group

UNM

Unum Group

N/A

Current Price

$72.52

Market Cap

12.0B

Sector

Finance

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$127.76

Market Cap

13.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNM
NBIX
Founded
1848
1992
Country
United States
United States
Employees
10910
N/A
Industry
Accident &Health Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
13.9B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
UNM
NBIX
Price
$72.52
$127.76
Analyst Decision
Buy
Strong Buy
Analyst Count
11
22
Target Price
$94.27
$175.23
AVG Volume (30 Days)
1.4M
1.2M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
N/A
$161,626,000.00
Revenue This Year
N/A
$22.85
Revenue Next Year
$4.84
$9.99
P/E Ratio
$17.16
$27.75
Revenue Growth
N/A
977.51
52 Week Low
$66.81
$84.23
52 Week High
$84.48
$160.18

Technical Indicators

Market Signals
Indicator
UNM
NBIX
Relative Strength Index (RSI) 46.07 42.16
Support Level $68.81 $122.82
Resistance Level $79.92 $128.99
Average True Range (ATR) 2.26 2.97
MACD 0.19 0.10
Stochastic Oscillator 62.32 19.66

Price Performance

Historical Comparison
UNM
NBIX

About UNM Unum Group

Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The Unum USA segment generates the majority of revenue. The firm markets its products through brokers.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: